Gregory Lodygensky PhD

Dr. Lodygensky is interested in the neurological trajectory of newborns at risk of brain damage, seeking to improve brain monitoring in the acute period, identifying neuronal disruptors, and introducing neuroprotective strategies in the neonatal period. In his fundamental research laboratory, the activities consist in particular in quantifying the lesion load and evaluating the effectiveness of neuroprotective therapies using multimodal MRI and new optical techniques in rodents, in correlation with histological studies. , biochemical and behavioral. In addition, thanks to the Canadian Neonatal Brain Platform established in September 2015.